TRIETHYL PHOSPHATE
General Information
Mainterm | TRIETHYL PHOSPHATE |
CAS Reg.No.(or other ID) | 78-40-0 |
Regnum |
175.105 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 6535 |
IUPAC Name | triethyl phosphate |
InChI | InChI=1S/C6H15O4P/c1-4-8-11(7,9-5-2)10-6-3/h4-6H2,1-3H3 |
InChI Key | DQWPFSLDHJDLRL-UHFFFAOYSA-N |
Canonical SMILES | CCOP(=O)(OCC)OCC |
Molecular Formula | C6H15O4P |
Wikipedia | triethyl phosphate |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 182.156 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 6 |
Complexity | 113.0 |
CACTVS Substructure Key Fingerprint | A A A D c c B g O A I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A A C A A A A C g g A I C A A A A A R A A Q A A A A I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 44.8 |
Monoisotopic Mass | 182.071 |
Exact Mass | 182.071 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 11 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9215 |
Human Intestinal Absorption | HIA+ | 0.9640 |
Caco-2 Permeability | Caco2- | 0.5303 |
P-glycoprotein Substrate | Non-substrate | 0.7973 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8140 |
Non-inhibitor | 0.8565 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.9310 |
Distribution | ||
Subcellular localization | Mitochondria | 0.7252 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8669 |
CYP450 2D6 Substrate | Non-substrate | 0.8498 |
CYP450 3A4 Substrate | Non-substrate | 0.6040 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9228 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8962 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9403 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8806 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9283 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8831 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8160 |
Non-inhibitor | 0.9382 | |
AMES Toxicity | Non AMES toxic | 0.9133 |
Carcinogens | Carcinogens | 0.8020 |
Fish Toxicity | High FHMT | 0.6025 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.7492 |
Honey Bee Toxicity | High HBT | 0.9135 |
Biodegradation | Not ready biodegradable | 0.8418 |
Acute Oral Toxicity | III | 0.8798 |
Carcinogenicity (Three-class) | Non-required | 0.5395 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -1.1362 | LogS |
Caco-2 Permeability | 0.3978 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.6232 | LD50, mol/kg |
Fish Toxicity | 2.0415 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | -0.5501 | pIGC50, ug/L |
From admetSAR
Toxicity Profile
Route of Exposure | None |
---|---|
Mechanism of Toxicity | None |
Metabolism | None |
Toxicity Values | None |
Lethal Dose | None |
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
Minimum Risk Level | None |
Health Effects | None |
Treatment | None |
Reference |
|
From T3DB
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organic acids and derivatives |
Class | Organic phosphoric acids and derivatives |
Subclass | Phosphate esters |
Intermediate Tree Nodes | Alkyl phosphates |
Direct Parent | Trialkyl phosphates |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Trialkyl phosphate - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as trialkyl phosphates. These are organic compounds containing a phosphate group that is linked to exactly three alkyl chains. |
From ClassyFire
Targets
- General Function:
- Zinc ion binding
- Specific Function:
- Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Isoform 3 is involved in activation of NOS3 and endothelial nitric oxide production. Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full length receptor. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3. Isoform 3 can bind to ERE and inhibit isoform 1.
- Gene Name:
- ESR1
- Uniprot ID:
- P03372
- Molecular Weight:
- 66215.45 Da
References
- Sipes NS, Martin MT, Kothiya P, Reif DM, Judson RS, Richard AM, Houck KA, Dix DJ, Kavlock RJ, Knudsen TB: Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays. Chem Res Toxicol. 2013 Jun 17;26(6):878-95. doi: 10.1021/tx400021f. Epub 2013 May 16. [23611293 ]
From T3DB